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Abstract
In mouse bearing progressive cancer a decrease was present in the allogeneic inhibitory activ-
ity of T-lymphocytes, which constitutes the core of immunological surveillance system in mam-
malians. For tests, methylcholanthrene-induced tumor (MC-tumor) was isografted subcutaneously
on the back between scapulae of C3H mice, and the lymphocytes were prepared from the regional
axillary lymph nodes removed from these mice at 1, 2, 3, or 4 weeks after grafting. These lymph
nodes cells were cultured together with 40-fold numbers of allogeneic JTC-11 cells derived from
Ehrlich cancer cells in a culture medium containing 2.0% (v/v) PHA for 24 or 48 hours. The prolif-
eration rate of JTC-11 cells (increased numbers) at weekly interval was considered the allogeneic
inhibitory activity of lymph node cells. As a result it was demonstrated that in the early stage
after tumor transplantation, i.e., in the first or second week, regional lymph node cells showed a
strong allogeneic inhibitory activity, as in the case with lymph-node cells from normal mice, but
at progressive stage of cancer, i.e., the third or fourth week when tumors were larger, such activity
was completely lost. It seems that mice with progressive cancer showed a decrease of allogeneic
inhibitory activity, i.e., a disruption of homeostasis was present.
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Abstract: In mouse bearing progressive cancer a decrease was
present in the allogeneic inhibitory activity of T-lymphocytes, which
constitutes the core of immunological surveillance system in mamma-
lians. For tests, methylcholanthrene-induced tumor (MC-tumor) was
isografted subcutaneously on the back between scapulae of C3H mice,
and the lymphocytes were prepared from the regional axillary lymph
nodes removed from these mice at 1, 2, 3, or 4 weeks after grafting.
These lymph nodes cells were cultured together with 40-fold numbers
of allogeneic JTC-ll cells derived from Ehrlich cancer cells in a cul-
ture medium containing 2.0% (v/v) PHA for 24 or 48 hours. The proli-
feration rate of JTC-ll cells (increased numbers) at weekly interval
was considered the allogeneic inhibitory activity of lymph node cells.
As a result it was demonstrated that in the early stage after tumor
transplantation, i. e., in the first or second week, regional lymph node
cells showed a strong allogeneic inhibitory activity, as in the case with
lymph-node cells from normal mice, but at progressive stage of cancer,
i. e., the third or fourth week when tumors were larger, such activity
was completely lost. It seems that mice with progressive cancer
showed a decrease of allogeneic inhibitory activity, i. e., a disruption
of homeostasis was present.
In our previous study of cell-mediated immunity of the cancer bearing
body from non-specific and specific aspects we reported that the cell-mediat-
ed immunity is decreased in progressive cancer (1, 2).
This time we studied the correlation between the change in allogeneic
inhibitory activity of lymphocytes, which belongs to the immunological
surveillance system (3), and the degree of cancer progress, and report that
such an allogeneic inhibitory activity decreased just as the lymphocytotoxic
activity of lymphocytes to target tumor cells decreases in progressive cancer.
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MATERIALS AND METHODS
Animals: The animals used were C3H male mice 6-10 weeks old procured
from The Mouse Colony of Okayama University.
Methods of successive maintenance of tumors: Tumors are maintained by
successive subcutaneous transplantations of methy1cholanthrene-induced tumor
(MC-tumor) obtained after injecting the arabian gum suspension containing
1 mg of 2O-methy1cholanthrene on the back of mice. MC-induced tumors
obtained at the sixth-eighth generations of successive transplantation were used
for the experiment.
Allogeneic target cells: JTC-ll cells derived from Ehrlich cancer cells and
being maintained at Department of Pathology, Okayama University, were
used as allogeneic target cells.
The preparation of lymphocyte suspension: After taking out lymph nodes
asceptically and slicing them into small pieces, they are passed through the 150-
mesh filters, the filtrate is centrifuged at 1,000 rpm for 10 min. and suspended
in the YLE solution (containing 30,u/ml Cephalothin) supplemented with 20 %
bovine serum to make the lymh node cell suspension.
Preparation of phytohemagglutinin (PHA): Immediately before use, one vial
(50mg) of phytohemagglutinin-M (Difco) was dissolved in 5ml YLE solution and
this serves as 100% (vIv) PHA solution.
Isografting of Me-tumor: Forty C3H mice are divided into four groups,
and 1mm3-piece of MC-tumor is transplanted subcutaneously on the back be-
tween the scapulae to each group of 10 mice at an interval of one week. After
lapse of one week from the last transplantation, i. e. at the time when all the
four groups of the first, second, third and fourth groups after MC-tumor
transplantation are ready for the test, 5 mice having tumors of similar size are
selected from each group, and under the ether anesthesia regional axillary
lymph nodes are extracted asceptically from each group of mice, and finally
lymph node cell suspensions are prepared from each group.
Estimation of allogeneic inhibitory activity: This is done according to the
method of KONAGA (4). Lymph node cells and JTC-ll cells are mixed in
the ratio of 40: 1, i. e. the mixture is 80 x 104 cells: 2x 104 cells/ml and to
the mixture is added 2.0% (v/v) of PHA to make the final volume IOml. The
mixed solution is put into 6 short test tubes each to contain 1. 5ml of it and the
stationary culture is carried out at 37°C by the method of EVANS et al. (5).
At 24 and 48 hours after the start of culture, three short test tubes are
picked out at random from each group, by decanting the culture medium, 1.5ml
crystal violet solution (composed of 2.1 g citric acid and 50mg of crystal violet
dissolved in lOOml of distilled water) is added to each tube, warmed to 37°C
for 3Omin. Cells on the test tube wall are scraped off gently with a cleaner,
and after shaking well the nuclear counts of tumor cells are taken of each test
tube several times with Burker-Turk hemocytometer. Those cells with a thin
nucleus showing distinct nucleoles are taken as tumor cells.
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RESULTS
Effects of the proliferation of MC-tumor after its isografting on the
allogeneic inhibitory of the host are as shown in Table. After the sub-
T ABLE. ALLOGENEIC INHIBITOR Y ACTIVITY OF REGIONAL LYMPH
NODE CELLS IN THE MOUSE ISOGRAFTED WITH MC-TUMOR
No. of ]TC-ll cells after culture·
(Mean ± S. E.••)
1ymph node cells PHA t-test·...
24 hr 48 hr
1 week after isografting + 3.17 ± 0.40 8.63 + 0.66 0.7<P<0.8
2 week after isografting + 2.97 ± 0.32 7.96 ± 0.83 0.6<P<0.7
3 week after isografting + 3.93 ± 0.51 12.69 ± 1.19 P<O.OOI
4 week after isografting + 3.90 ± 0.29 11.12 ± 1.03 P<O.OOI
normal lymph node cells + 3.13 ± 0.28 8.25 ± 0.59
(control)
]TC-ll cells alone 4.31 ± 0.28 11.94 ± 0.64
• X 104
•• Standard error
••• Significant differance between control group by Student's t-test.
cutaneous transplantation of 1mm3 MC-tumor, the tumor grows to the size of
a rice grain one week later, by two weeks it is as big as small finger tip, by
3 weeks it is the size of thumb head, and by the fifth to sixth week the
animals die of tumor. The tumors at the third to fourth post-transplantation
week correspond to advanced stage. The allogeneic inhibitory activity of
regional axillary lymph node cells of cancer-bearing mice at relatively early
stage of one to two weeks after the isografting against JTC-ll cells is as
strong as that of normal lymphocytes, showing a strong suppression of the
proliferation of JTC-ll cells. However, the allogeneic inhibitory activity
of regional lymph node cells 3-4 weeks after transplantation is markedly
disturbed, showing not any inhibitory effect on the proliferation of JTC-ll
cells, and there can be observed an increase in the number of JTC-ll cells
just as in the case ot the culture of JTC-ll cells alone (control group) or
mixed culture of normal lymph node cells and JTC-ll cells in the absence of
PHA. In other words, the allogeneic inhibitory activity of the lymph node
cells at the third or fourth week is completely lost.
DISCUSSION
As for the non-specific functions of T-lymphocytes in the cancer bearing
body the studies in the past were concerned with the skin reactions in VillO
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such as tuberculin reaction and DNCB reaction (1), and in vitro the blastfor-
mation rate of lymphocytes against allogeneic cells or the blastformation rate
to PHA, and in either instance it is reported that the blastformation rate is
decreased in progressive cancer (6). However, there is as yet no report about
allogeneic inhibitory activity that is one of the important functions of T-
lymphocytes. Allogeneic inhibition has been noticed relatively recently by
MOLLER (7), and under certain culture conditions it destroys allogeneic cells
by inducing non-immune lymphocytes to adhere and aggregate non-specifi-
cally onto allogeneic cells. It is considered that this allogeneic inhibition is
the activity possessed by all somatic cells including lymphocytes in order to
eliminate any undesirable cells that have deviated from their normal activity
and it is believed to play an important role in the immunological surveil-
lance system of the body.
On the other hand, lymphocytotoxicity or immune lymphocytes, one of
the most representative of the specific cell-mediated immunity, is also initiated
by the adherence and aggregation of lymphocytes onto target cells. The
similarity between the mechanism of the destruction of allogeneic cells by
non-immune lymphocytes and the mechanism of destruction of specific target
cells by immune lymphocytes has already been reported in detail by KONAGA
(8), and there appears to be a quite similarity between the two mechanisms.
In the present experiment likewise observations were made on the lym-
phocytotoxicity in the mixed cultures of regional axillary lymph node cells
prepared from C3H mice to which the MC-tumor of the same strain of animals
was transplanted subcutaneously on the back and with lapse of one, two,
three, and four weeks after transplantation. As a result a strong cytotoxic
activity being generated in the regional lymph node cells was observed at a
relatively early stage of the first or the second week, whereas by the third or
fourth week when the tumor had grown larger, i. e. in the advanced stage,
such an activity was completely lost as mentioned by our previous study (9).
The change in the specific cytotoxic activity of immune lymphocyte and
that in the allogeneic inhibitory activity are well correlated.
In the background of the decreasing tendency of specific cell-mediated
immunity in the progressive cancer there can be assumed a decrease in allo-
geneic inhibitory activity. The mechanisms of such an activity decline are
quite complex, but the loss of such an allogeneic inhibition means an irrepar-
able deviation of homeostasis, hence indicating the worsening of progressive
cancer.
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